{
    "Trade/Device Name(s)": [
        "GLUCOCARD 01-mini Blood Glucose Monitoring System",
        "ReliOn Micro Blood Glucose Monitoring System",
        "GLUCOCARD 01 SENSOR PLUS Blood Glucose Test Strips",
        "ReliOn Micro Plus Blood Glucose Test Strips"
    ],
    "Submitter Information": "ARKRAY Factory, Inc.",
    "510(k) Number": "K142035",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082417"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "July 24, 2014",
    "Summary Letter Received Date": "July 28, 2014",
    "Submission Date": "July 17, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GLUCOCARD 01-mini Blood Glucose Meter",
        "ReliOn Micro Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strips",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for GLUCOCARD 01-mini and ReliOn Micro blood glucose monitoring systems and related test strips for quantitative measurement of glucose in fresh capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip or palm for home use by persons with diabetes to monitor effectiveness of diabetes control; not for diagnosis, screening, or neonatal use; for single patient use only.",
    "fda_folder": "Clinical Chemistry"
}